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Background: There is scarcity of data concerning retirement and workforce loss exclusively in patients with type 1
diabetes. The aim of this study was to evaluate the prevalence, causes, and predictors of retirement in patients with
type 1 diabetes in Brazil.
Methods: This was a multicenter cross-sectional study conducted between December 2008 and December 2010 in
28 public clinics in 20 Brazilian cities. Data were obtained from 3,180 patients aged 22 ± 11.7 years; 56.3% of the
participants were female, and 57.4% were Caucasians. The mean time since diabetes diagnosis was 10.3 ± 8.1 years.
Patients’ information (clinical factors and retirement data) was obtained through a questionnaire and a chart review.
Patients were retired by diabetes according to the Brazilian Institute of Social Security’s criteria that takes in account
the presence of diabetes-related chronic complications certified by a doctor, excluding any personal reason or
another health condition besides diabetes. Both quantitative and qualitative tests were employed, and a multivariate
logistic regression model was performed to identify the factors associated with retirement due to disabilities in patients
with type 1 diabetes.
Results: The overall frequency of retirement was 4.2%, with no difference between genders. The mean age of retirement
was 35.5 ± 9.3 years, resulting in 17.5 ± 9.1 years of workforce losses. These patients had a significantly higher prevalence
of severe hypoglycemia, proliferative and non-proliferative retinopathy, foot disorders, chronic or end-stage renal disease
requiring dialysis or transplantation, cataracts, glaucoma, psychological disorders, hypertension, and overweight/obesity
than did the employed patients. Multivariate logistic regression analysis with retirement as the dependent
variable showed adjusted odds ratios (ORs) of 4.87 (2.66-8.78) for the presence of microvascular complications
and 3.7 (2.04-6.70) for macrovascular complications.
Conclusions: Retirement due to disabilities occurred in 4.2% of Brazilian patients with type 1 diabetes at an early
age and is strongly associated with diabetes-related chronic complications. Health care workers should thus
reevaluate the quality of care given to these patients.
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The incidence of type 1 diabetes (T1D) is increasing
worldwide along with its chronic complications and has
become a major health problem and financial burden be-
cause of its high direct and indirect costs [1-7]. The indir-
ect costs of diabetes are primarily related to productivity
losses due to disability, early retirement, unemployment,
and absenteeism caused by acute and chronic complica-
tions [4,8,9]. Patients with diabetes generally participate
less in the workforce than subjects without diabetes of the
same age and gender, as indicated by the indirect costs of
diabetes reported by the Health and Retirement Study
(HRS) conducted in the US [10]. At baseline, patients with
diabetes in the HRS were less educated and had more co-
morbidities, such as hypertension, coronary artery disease,
stroke, congestive heart failure, visual impairment, kidney
and foot problems, than individuals without diabetes [10].
This study as well as the GAZEL study conducted in
France [11] have linked diabetes with greater risks of dis-
ability, retirement, and early death. However, these studies
were conducted in predominantly middle-aged patients
with type 2 diabetes. Another study conducted in the US
evaluating the sociodemographic characteristics of per-
sons with diabetes has found that patients with T1D have
a lower probability of employment and higher rates of ab-
senteeism and early retirement [12]. However, it is import-
ant to emphasize that so far there are few data in the
international literature including Brazil on this topic,
which is a very important issue because of its long-lasting
consequences for patients and society.
This study aimed to evaluate the prevalence, and clin-
ical factors related to retirement in patients with T1D in
Brazil.
Methods
This multicenter, retrospective, cross-sectional, observa-
tional study was conducted between December 2008 and
December 2010 in 28 public secondary (ambulatory out-
patient clinics) and tertiary care-level clinics (ambulatory
outpatient clinics in university hospitals) located in 20
cities in four Brazilian geographic regions (north/north-
east, mid-west, southeast, and south). The details of the
data collection methods have been published previously
[13,14]. All patients received healthcare from the Brazilian
National Health Care System (BNHCS). All eligible par-
ticipating centers had a diabetes clinic with at least one
endocrinologist which provided data from a minimum of
50 consecutive outpatients with diagnosis of T1D who
regularly attended the clinic. The inclusion criteria con-
sisted of a diagnosis of T1D by a physician that was based
on the typical clinical presentation, including variable de-
grees of weight loss, polyuria, polydipsia and polyphagia,
and the need for continuous insulin use since the diagno-
sis of T1D. All patients were diagnosed between 1960 and2010. Patients who did not fulfill these criteria were ex-
cluded from the study. A total of 3,591 patients were
enrolled.
The ethics committee form the Pedro Ernesto Univer-
sity Hospital that belongs to the State University of Rio
de Janeiro approved the study as did all the local ethics
committees of each center (Appendix 1). Written in-
formed consent was obtained from all patients or their
parents, as appropriate.
Demographic, educational, economic, and working sta-
tus data and the following variables were assessed in an
interview during a clinical visit: age, age at diagnosis,
duration of diabetes, blood pressure, modalities of treat-
ment, comorbidities, frequent severe hypoglycemia (self-
reported), and smoking status. The levels of glycated
hemoglobin (HbA1c), fasting plasma glucose (FPG), total
cholesterol, low-density lipoprotein (LDL) cholesterol,
high-density lipoprotein (HDL) cholesterol, and triglyc-
erides measured at the last clinical visit were obtained
from medical records. The screenings for retinopathy,(by
fundoscopy; classified as absent, non-proliferative, or
proliferative [15]), clinical nephropathy (by microalbumi-
nuria, classified according to ADA recommendations
[15]), macrovascular diseases (clinical coronary artery
disease, stroke, and peripheral vascular disease), and foot
pathologies in patients with diabetes duration equal or
greater than five years were evaluated in medical records
when these procedures were performed within one year of
the study assessment. Hospitalization for diabetes ketoaci-
dosis, hyperglycemia without DKA and hypoglycemia in
the previous year were also investigated.
The following ADA goals for adequate metabolic and
clinical control [15] were adopted by the BrazDiab1SG:
HbA1c < 7%; systolic blood pressure (sBP) < 130 mmHg;
diastolic blood pressure (dBP) < 80 mmHg; body mass
index (BMI) < 25 kg/m2; FPG < 130 mg/dl (7.2 mmol/l);
total cholesterol < 200 mg/dl (5.2 mmol/l); HDL choles-
terol > 40 mg/dl for men (1.1 mmol/l) and > 50 mg/dl
(1.3 mmol/l) for women; LDL cholesterol < 100 mg/dl
(2.6 mmol/l); non-HDL cholesterol < 130 mg/dl
(3.30 mmol/l) and triglycerides < 150 mg/dl/l (1.7 mmol/l).
Hypertension was defined as sBP ≥ 140 mmHg and/or
dBP ≥ 90 mmHg, as measured during the last clinical
visit [8] or self-reported. Overweight was defined as a
BMI ≥ 25 kg/m2, and obesity was defined as a BMI ≥
30 kg/m2 [15]. The HbA1c values obtained in the last
clinical visit in 2,768 patients (87%) were measured
using a method certified by the National Glycohemo-
globin Standardization Program (NGSP), namely, high-
performance liquid chromatography (1,514 patients,
54.7%) or turbidimetry (1,254 patients, 45.3%). HbA1c
levels that were determined using other methods, missing
data, and HbA1c measurements obtained more than one
year prior to the study assessment were excluded from the
Figure 1 Flow chart of the patients included in the present study.
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ides, HDL cholesterol, and total cholesterol were mea-
sured using enzymatic techniques. LDL cholesterol was
calculated using Friedewald’s equation [16]. Current
smoking was defined as smoking more than one cigarette
per day at the time of the interview.
Sample calculation, economic status
A detailed description of the study sample calculation has
been described previously [13,14]. Briefly, the study sample
represented the distribution of T1D cases across four geo-
graphic regions of Brazil. This distribution was estimated
using the overall population distribution reported in the
2000 Brazilian Institute of Geography and Statistics Popula-
tion Census (IBGE) [17]. These data were combined with
national estimates of diabetes prevalence derived from a
1988 survey to determine the minimum number of patients
to be studied in each region [18]. Economic status was de-
fined according to the Brazilian Economic Classification
Criteria [19]. This classification also accounts for education
level: illiterate/incomplete primary education, complete pri-
mary education/incomplete secondary education, complete
secondary education/incomplete high school, complete
high school/some college, or college graduate. The follow-
ing economic status categories were considered for this
analysis: high, middle, low, and very low [19].
Sample of the present study
In the present study we included patients with at least one
year of medical follow-up at each respective center (n =
3,180) and patients who fulfilled the criteria of Brazilian
Institute of Social Security (BISS), which determines that
only individuals older than 15 years could be employed,
and only individuals with at least one year of continuous
employment could be retired [20]. We also excluded from
the present study patients with T1D who retired at the ex-
pected age (n = 22, 0.7%), patients who presented no cri-
teria to be either employed or retired (n = 1,106, 34.8%),
and patients with permanent disability due to other dis-
eases [n = 6, 0.2% (Down syndrome, n = 4; congenital am-
aurosis, n = 1; and schizophrenia, n = 1)] . The final
sample of the present study was n = 2,046 patients which
is summarized in the flow chart described in Figure 1. Pa-
tients were retired by diabetes according to the Brazilian
Institute of Social Security’s criteria that takes in account
the presence of diabetes-related chronic complications
certified by a doctor, excluding any personal reason or an-
other health condition besides diabetes [20]. Workforce
loss was estimated based on the age at retirement because
of T1D and the age of retirement in the general Brazilian
population, which is 55 years for men and 52 years for
women [20]. After this age, workers quit their labor activ-
ity and start receiving benefits from the BISS. An individ-
ual is considered to be early retired when receivingbenefits for any reason, including by disabilities due to
diabetes, before the above mentioned age [20].
Statistical analysis
The data were presented as the means (± SD) or median
(minimum-maximum) for continuous variables and as
counts (relative frequencies) for discrete variables. All the
variables were tested for normality distribution. When a
normal distribution was observed parametric tests were
used; otherwise non-parametric tests were applied. A
multivariate logistic regression model was performed with
retirement (yes/no) as the dependent (outcome) variable
and the presence of microvascular and macrovascular
complications as the independent (exposure) variables.
Other predictive variables, such as socioeconomic status,
ethnicity (Caucasian or non-Caucasian, based on self-
reporting), age, geographic region, gender, and duration of
diabetes, were controlled in the analysis using a stepwise
regression analysis. The following steps were applied for
modeling: (1) baseline model (social and demographic
characteristics, such as gender, ethnicity, social class and
region), (2) introduction of the variable disease duration
and (3) final models, with introduction of the independent
variables: minor complications and major complications.
Workforce losses were only estimated based on age of re-
tirement of Brazilian men (55 years) and women (52
years). All analyses were performed using the Statistical
Package for the Social Sciences (SPSS version 17.0, SPSS,
Inc., Chicago, Illinois, USA). Odds ratios with 95% con-
fidence intervals (CIs) were calculated when indicated.
A two-sided p value less than 0.05 was considered
significant.
Results
Overview of participant demographics, socioeconomic
status, level of care, and insulin treatment
Data were obtained from 3,180 patients (excluded n = 411,
11.5%). The average follow-up time in each respective dia-
betes center was 6.1 (1-49) years. The economic status of
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(34.7%)] or low [n=1,052 (33.1%)]. Combined intermediate
or long-acting insulin and short-acting insulin was the
most common therapeutic regimen [2,334 (84.3%) pa-
tients]. Most patients reported using three or more daily
injections of short-acting insulin (1,785 patients, 56.2%)
and three or more SBGM daily tests (1,907 patients, 60%).
The demographic data of this population are listed in
Table 1.
Overview of the overall frequency of retirement,
demographic data, level of care and related workforce
losses
The overall frequency of retirement due to diabetes in
patients who met the BISS criteria of retirement was
4.2% with no difference between men and women. No




Female, n (%) 1,791 (56.3)
Age, y 22 ± 11.8













Very low 1,102 (34.7)
Retirement, n (%)
No criteria for retirement*** 1,106 (34.8)
Retired at the expected age 22 (0.7)
Not retired 1,961 (61.7)
Retired because of DM 85 (2.7)
Level of care n (%)
Secondary 897 (28.2)
Tertiary 2,283 (71.8)
Duration of diabetes, y 10.3 ± 8.04
y = year; data are presented as number (percentage) or mean ± SD.
*African-Brazilians, Mulattos, Asians, and Native Indians.
**Missing data from 87 participants; ***Patients younger than 16 y.was observed between genders (men: 37.4 ± 9.4 vs women:
34.4 ± 9.0, p = 0.14). The mean duration of retirement due
to diabetes was 6 (<1-30) years. The time of follow-up in
each center was greater in patients who had retired because
of diabetes than in patients who were employed (12.3 ±
9.8 years vs 7.9 ± 6.1 years, p < 0.001). The proportion of
patients who were treated at the tertiary care level center
was higher in the retired group than in the employed group
[n = 74 (87.1%) vs 1,414 (72.1%), p = 0.001]
The estimated mean workforce losses in years in pa-
tients who had retired due to diabetes was almost 17
years in both genders. The demographic, clinical, and la-
boratory data of patients who retired because of T1D
and employed patients are compared in Table 2.Overview of frequency of retirement due to diabetes and
the coexistence of cardiovascular risk factors
Overweight or obesity was noted in 651 patients (31.8%).
Patients who retired due to diabetes were more likely to
be overweight or obese than were employed patients [36
(42.9%) vs 615 (31.5%), p <0.03]. Hypertension was ob-
served in 563 (27.5%) patients. The frequency of hyper-
tension was greater among those who had retired
because of diabetes than among employed patients [61
(72.6%) vs 502 (26.1%), p <0.0001]. There were no
between-group differences in the proportions of patients
who achieved their target LDL cholesterol, total choles-
terol or HDL cholesterol levels. Fewer patients who had
retired because of diabetes reached their triglycerides
targets [62 (76.5%) vs 1432 (84.2%), p <0.07]. Overall,
486 (23.8%) patients were receiving antihypertensive
agents, and 253 (12.4%) patients were receiving statins.
Patients who had retired because of diabetes were more
likely to use antihypertensive agents than employed
patients [48 (56.5%) vs 438 (22.3%), p < 0.0001)] and
were also more likely to use statins [28 (32.5%) vs 225
(11.5%), p < 0.0001].Overview of diabetes treatment modality, glycemic
control, and the coexistence of acute and chronic
diabetes-related complications in patients with retirement
Patients who had retired because of diabetes were less
likely to use combined insulin therapy than were employed
patients [58 (69.9%) vs 1,638 (84.8%), p = 0.0002]. No dif-
ferences in the total number of insulin injections, total
number of daily SBGM tests, or HbA1c levels were ob-
served between patients who had retired because of dia-
betes and employed patients.
No differences in the frequencies of hospitalization be-
cause of hypoglycemia, hyperglycemia or diabetes ketoa-
cidosis were observed between patients who had retired
because of diabetes and employed patients [8 (9.4%) vs
145 (7.4%), p = 0.6] and [2 (2.4%) vs 85 (4.3%), p = 0.4].
Table 2 Economic and medical variables in retired type 1 diabetes patients and employed patients
Variable Retirement* P-value
Yes (%) No (%)
N 85 (4.2) 1,961 (95.8) -
Age 42.7 ± 10.6 26.9 ± 9.2 <0.001
Age at diagnosis of diabetes, y 18.5 ± 9.1 14.2 ± 7.9 <0.001
Female, n (%) 44 (51.8) 1,120 (57.1) 0.27
Duration of diabetes, y 24.2 ± 9.1 12.7 ± 7.7 <0.001
Ethnicity* 0.05
Caucasian 57 (67.4) 1,120 (57.1)
Non-Caucasian* 28 (32.6) 841 (42.9)
Economic status, n (%) 0.01
High 2 (2.3) 195 (9.9)
Medium 21 (25.6) 529 (26.9)
Low 27 (31.1) 690 (35.2)
Very low 35 (40.7) 547 (27.9)
Geographical region 0.02
North/Northeast 13 (15.1) 589 (30.1)
Southeast 44 (51.2) 776 (39.6)
South 23 (27.9) 472 (24.1)
Midwest 5 (5.8) 123 (6.3
BMI 24.6 ± 4.0 23.5 ± 3.6 0.005
Overweight or obesity, n (%) 36 (42.9) 615 (31.5) 0.03
Fasting glycemia (mg/dL) 191.2 ± 115.5 177.7 ± 104.1 0.2
HbA1c (%)HbA1c (mmol/mol) 8.9 ± 1.874 ± 19.7 9.3 ± 2.378 ± 25.1 0.2
HbA1c <7.0%, n (%) 6 (7.6) 244 (14.4) 0.9
HbA1c ≥9.0%, n (%) 34 (43.0) 799 (47.2) 0.2
sBP (mmHg) 128.1 ± 16.7 116.8 ± 16.0 <0.001
dBP (mmHg) 79.8 ± 9.8 74.9 ± 10.8 <0.001
Total cholesterol (mg/dL) 173.9 ± 44.2 173.2 ± 43.3 0.8
Triglycerides (mg/dL) 121.8 ± 116.6 95.3 ± 70.8 0.001
HDL cholesterol (mg/dL) 54.6 ± 18.3 53.1 ± 15.2 0.4
LDL cholesterol (mg/dL) 96.4 ± 34.6 101.5 ± 34.5 0.19
Current smoker, y (%) 4 (4.7) 123 (6.3) 0.06
Insulin dose (U/kg/day) 0.68 ± 0.35 0.87 ± 0.35 <0.001
Number of clinical visits (previous year) 4.3 ± 1.7 3.9 ± 1.6 0.01
Chronic complications, n (%)
Microvascular 68 (80.0) 538 (31.6) <0.0001
Macrovascular 27 (31.8) 85 (5.0) <0.0001
Micro and macrovascular 69 (81.2) 575 (33.8) <0.0001
Foot pathologies, n (%)
Ulcer 4 (4.7) 31 (1.8) 0.16
Amputation 9 (10.6) 9 (0.5) <0.0001
Charcot arthropathy 2 (2.4) 5 (0.3) 0.01
Severe hypoglycemia 22 (37.9) 228 (18.5) 0.007
Overweight and obesity were considered together.
The data are presented as number (percentage) or mean ± SD.
*African-Brazilian, Mulatto, Asian, or Native Indian.
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Table 3 Final adjusted logistic regression model of early
retirement because of type 1 diabetes and the presence
of microvascular complications in Brazil (n = 2,046)
N OR (95% CI) Adjusted P-value
Microvascular complications
Yes 606 4.87 (2.71-8.78) <0.001
No 1,181 - Reference
Socioeconomic statusa
High 197 - Reference
Medium 550 6.57 (1.31-32.97) 0.022
Low 717 6.81 (1.37-33.80) 0.019
Very low 582 10.58 (2.15-52.16) 0.004
Ageb 2,046 1.09 (1.06-1.12) <0.001
Duration of diabetesb 2,046 1.05 (1.02-1.09) 0.004
aReference: high socioeconomic status.
bContinuous variables.
Table 4 Final adjusted logistic regression model of early
retirement because of type 1 diabetes and the presence
of macrovascular complications in Brazil (n = 2,046)
N OR (95% CI) Adjusted P-value
Macrovascular complications
Yes 112 3.70 (2.04-6.70) <0.001
No 1,675 - Reference
Socioeconomic statusa
High 197
Medium 550 9.08 (1.69-48.9) 0.010
Low 717 8.67 (1.63-46.05) 0.011
Very low 582 13.42 (2.54-70.92) 0.002
Ageb 2,046 1.08 (1.05-1.11) <0.001
Duration of diabetesb 2,046 1.06 (1.03-1.10) <0.001
aReference: high socioeconomic status.
bContinuous variables.
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2,046), among patients who had undergone fundoscopy
in the previous year (n = 1,596; 78%), patients who had
retired because of diabetes were more likely than were
employed patients to have proliferative retinopathy or
non-proliferative retinopathy [32 (43.2%) vs 122 (8.7%),
p < 0.0001 and 23 (31.1%) vs 156 (11.2%), p < 0.0001, re-
spectively]. More patients who had retired because of
diabetes than employed patients had undergone laser
therapy and vitrectomy [43 (50.6%) vs 137 (8.1%), p <
0.0001 and 7 (8.2%) vs 27 (1.6%), p < 0.0001, respect-
ively]. Additionally, higher proportions of the retired pa-
tients than of the employed patients had cataracts and
glaucoma [13 (15.3%) vs 100 (5.9%), p < 0.0001 and 7
(7.1%) vs 58 (3.4%), p < 0.001, respectively].
Furthermore, among patients for whom renal function
data had been measured within the previous year (n =
1,529;75%), those who had retired because of diabetes
were more likely to have clinical nephropathy [11 (12.9%)
vs 84 (4.9%)], chronic renal disease receiving conservative
treatment [6 (7.1%) vs 36 (2.1%)], or chronic renal disease
requiring dialysis treatment [7 (8.2%) vs 16 (1.0%)] or to
have undergone renal transplantation [5 (5.9%) vs 4
(0.2%)] (p < 0.010 for all comparisons). No difference was
observed concerning demographic and clinical data be-
tween patients who had or not information about the sta-
tus of retinopathy or nephropathy (data not shown).
Other complications, such as cataracts (n = 2), severe
hypoglycemia (n = 2), and psychological disorders (n = 5)
without any chronic complications, were observed only
in patients with retirement because of diabetes. The dis-
tribution of diabetes-related complications is shown in
Table 2.
Using unadjusted multivariate analysis with retirement
because of diabetes as the dependent variable, the odds
ratios (ORs) given the presence of macrovascular and
microvascular complications were 9.02 (95% CI 5.43-
14.97, p < 0.001) and 9.20 (95% CI 5.29-16.02, p < 0.001),
respectively. The adjusted models are shown in Tables 3
and 4. The discriminatory capacity and adjustment param-
eters of the models is showed in Table 5.
Discussion
To the best of our knowledge, this is the first study ad-
dressing retirement exclusively in patients with T1D.
We have found that in our sample of patients with
T1D who met the criteria of BISS for retirement, 4.2%
were already retired. The majority of these patients with
retirement because of diabetes did it early, and had ei-
ther acute (frequent severe hypoglycemia) or chronic
diabetes-related complications and were from low or
very low socioeconomic status. Our results provide evi-
dence of a significant impact of T1D and related compli-
cations causing disabilities and early retirement in Brazil.We have found that among our young cohort, the ma-
jority were on working age and in the most productive
years of their lives.
The association of disabilities caused by diabetes with
early retirement is largely diabetes-related chronic compli-
cations, such as retinopathy, nephropathy, macrovascular
disease, and foot pathologies, and similar complications
were observed in both genders. Our data are similar to
those of the HRS conducted in the US [10], which showed
that retired individuals with diabetes generally had more
comorbidities and a higher probability of self-reported dis-
ability than those without diabetes.
Other complications, such as cataracts, glaucoma, se-
vere hypoglycemia, and psychological disorders without
any chronic complications, were observed only in patients
with early retirement due to disabilities caused by dia-
betes. According to a study conducted in Spain, which did
not evaluate data concerning early retirement, severe
Table 5 Discriminatory capacity and adjustment of models for predicting retirement
Model -2 log likelihood Cox & Snell R Square Nagelkerke R Square
Baseline modela 521,934 ,087 ,296
Baseline model + duration of diseaseb 508,358 ,093 ,317
Final model: Model 2 + microvascular complication 468,837 ,110 ,349
Final model: Model 2 + macrovascular complication 485,017 ,102 ,324
aSocial and demographic characteristics: gender, age, ethnicity, region, and socioeconomic status.
bGender, ethnicity, and region were excluded due to lack of statistical significance.
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on healthcare costs [8].
Patients that retired early used less complex insulin
treatment regimens, were more frequently treated at sec-
ondary care clinics, and were more likely to be of medium,
low or very low socioeconomic status compared with
those patients who were not retired. Although the BNHCS
is universal, and every Brazilian citizen can look for free
medical attention, when people retire their earnings
become lower than when they are actively working. This
will generally imply in a worsening of their socioeconomic
status.
Our study has also shown that glycemic control was
not associated with early retirement due to disabilities
caused by diabetes. However, this finding must be inter-
preted with caution because more than 40% of our pa-
tients had HbA1c levels greater than 9.0% and because it
is difficult to establish causal relationships in cross-
sectional studies such as ours. The Diabetes Control and
Complications Trial (DCCT) [21] and DCCT/Epidemi-
ology of Diabetes Interventions and Complications Study
(EDIC) [22] have shown that effective diabetes control
decreases the risk of developing chronic microvascular
complications [21,22]. Recently, the EDIC showed that
excess weight gain in DCCT was associated with the
presence of metabolic syndrome markers [23]. Our pa-
tients who retired early due to disabilities caused by dia-
betes had more comorbidities, such as hypertension,
overweight/obesity and increased triglycerides levels.
Considering that intensive management of glycemia,
weight, cholesterol, and blood pressure are effective in
delaying or preventing diabetes-related complications
[24-27], it is imperative to change the approach for these
patients to a proactive model that could probably prevent
the occurrence of diabetes-related chronic complications
and thus the probability of early retirement due to
disabilities.
The mean age of retirement due to disabilities caused by
diabetes in our patients was 34.0 years for women and
37.4 years for men. This is a worrying situation consider-
ing that the standard age of retirement in the general
population in our country is 52 years for women and
55 years for men [20]. These data show that early retire-
ment in patients due to disabilities caused by diabetesresults in more than 15 years of workforce loss per retired
patient in Brazil.
Retirement generally coincides with deterioration of
one's health and correlates with increasing age; these
statistics may predict greater expenses for the public
health systems in both developing and developed coun-
tries [28]. In Brazil, each patient with T1D represents an
average annual direct medical cost of 1319.15 US dollars
[29]. We have no national data about the amount of an-
nual indirect costs spent with this setting of patients and
this must be addressed in future studies.
The strengths of our study include its large sample size
that represents the diverse, young Brazilian population with
T1D and includes a wide range of ethnic groups and socio-
economic backgrounds from all geographic regions of the
country. The data were collected with a uniform, standard-
ized recruitment protocol which provided data from a
minimum of 50 consecutive outpatients with diagnosis of
T1D who regularly attended the clinics in all participating
centers and therefore represent a large occupational cohort.
However, our study has several limitations that must be
addressed. One limitation was the sample characteristics
and study design. All patients lived in large cities and re-
ceived care from a specialist at a public health center; thus,
patients who relied on primary care facilities and lived in
rural areas may not have been considered. However, the
latter group represents a small minority of T1D patients
receiving treatment in Brazil (less than 1% according to the
diabetes prevalence survey conducted in 1988) [18]. Our
study design was retrospective, cross-sectional, mainly ex-
ploratory so it did not allow us to establish a causal rela-
tionship. Another limitation of our study was the absence
of psychosocial evaluation. Family support and patient self-
efficacy have been associated with positive outcomes in-
cluding better glycemic control, which in many cases could
help to avoid or postpone T1D-related complications and
consequent early retirement due to disabilities. The occur-
rence of self-reported hypoglycemia as the cause of retire-
ment in two patients without diabetes-related chronic
complications could also be considered a limitation of our
study. Other limitation was related to the relationship be-
tween the evaluation of clinical outcomes and retirement,
since the majority of the retired patients had retired before
this evaluation.
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In conclusion, 4.2% of our patients who met the BISS cri-
teria to be retired had early retirement mainly because of
diabetes-related chronic complications. Thus, it is impera-
tive that Brazilian diabetes care teams change the educa-
tion and follow-up approaches used for patients with T1D.
A more proactive model would help prevent or postpone
the occurrence of chronic complications and consequently
early retirement due to disabilities caused by diabetes,
which may in many ways worsen an already compromised
quality of life. Further studies are necessary to establish
the costs of productivity losses due to early retirement
due to disabilities caused by diabetes. Finally, early retire-
ment due to disabilities must be considered an important
issue in the subset of patients with T1D.
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